An Open-label Phase I/II Study of JR-446 in Mucopolysaccharidosis Type IIIB
Clinical trial NCT06488924 · RECRUITING
Trial details
- NCT number
- NCT06488924
- Sponsor
- JCR Pharmaceuticals Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-05
- Primary completion
- 2030-04-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.